首页 | 本学科首页   官方微博 | 高级检索  
检索        

【特刊综述】雄激素对骨骼肌的作用:对乏力的发展和治疗的意义
引用本文:Matthew DL O'Connell,Frederick CW Wu.【特刊综述】雄激素对骨骼肌的作用:对乏力的发展和治疗的意义[J].亚洲男性学杂志,2014,16(2):203-212,I0007,I0008.
作者姓名:Matthew DL O'Connell  Frederick CW Wu
作者单位:[1]The Irish Longitudinal Study on Ageing, Department of Medical Gerontology, Trinity College, Dublin, Ireland [2]Andmlogy Research Unit, Institute of Human Development, Centre for Endocrinology and Diabetes, University of Manchester, Manchester, UK.
摘    要:雄激素对骨骼肌合成有明显影响,随着年龄增大,雄激素的下降常伴随肌量和肌力的下降。这种肌量和肌功能的下降,被称为少肌症或肌体老化,是老年人体质弱化(男性化减退)进展的关键事项。也是导致快速机能衰退及其不良后果的关键。雄激素水平下降对老年男性体质弱化(男性化减退)的潜在影响和对躯体功能的促进治疗作用无疑已经引起了相当的关注。本综述概述了近期关于肌肉老化、少肌症、老年体质弱化的概念、定义,并评估了关于雄激素和老年体质弱化的研究进展。近期源于观测性和介入性研究的证据强烈支持雄激素对老年男性肌量的作用,但雄激素对肌力和特有的躯体功能的效用并不明确。研究显示,雄激素治疗在老年男性中通常有良好的耐受性,而近期的研究则关注于雄激素的高剂量治疗和对于心血管风险较高人群的治疗。雄激素受体调节剂(SARMs)的初期试验研究显示传统雄激素治疗对于老年患者在肌量和肌功能方面有相同的效用。将来的重要研究方向包括利用这类雄激素治疗并结合适用于不同老年患者群体促进躯体功能的运动训练,同时将更多地关注近期关于激素水平、身体成分及躯体功能间关系的观测性(回顾性)研究。

关 键 词:老化  雄激素  身体成分  体质弱化  肌肉  躯体功能  少肌症  雄激素受体调节剂  性激素  睾酮
收稿时间:2013 Aug 15

Androgen effects on skeletal muscle: implications for the development and management of frailty
Matthew DL O’Connell,Frederick CW Wu.Androgen effects on skeletal muscle: implications for the development and management of frailty[J].Asian Journal of Andrology,2014,16(2):203-212,I0007,I0008.
Authors:Matthew DL O’Connell  Frederick CW Wu
Institution:1.The Irish Longitudinal Study on Ageing, Department of Medical Gerontology, Trinity College, Dublin, Ireland;2.Andrology Research Unit, Institute of Human Development, Centre for Endocrinology and Diabetes, University of Manchester, Manchester, UK
Abstract:Androgens have potent anabolic effects on skeletal muscle and decline with age in parallel to losses in muscle mass and strength. This loss of muscle mass and function, known as sarcopenia, is the central event in development of frailty, the vulnerable health status that presages adverse outcomes and rapid functional decline in older adults. The potential role of falling androgen levels in the development of frailty and their utility as function promoting therapies in older men has therefore attracted considerable attention. This review summarizes current concepts and definitions in muscle ageing, sarcopenia and frailty, and evaluates recent developments in the study of androgens and frailty. Current evidence from observational and interventional studies strongly supports an effect of androgens on muscle mass in ageing men, but effects on muscle strength and particularly physical function have been less clear. Androgen treatment has been generally well-tolerated in studies of older men, but concerns remain over higher dose treatments and use in populations with high cardiovascular risk. The first trials of selective androgen receptor modulators (SARMs) suggest similar effects on muscle mass and function to traditional androgen therapies in older adults. Important future directions include the use of these agents in combination with exercise training to promote functional ability across different populations of older adults, as well as more focus on the relationships between concurrent changes in hormone levels, body composition and physical function in observational studies.
Keywords:ageing  androgens  body composition  frailty  muscle  physical function  sarcopenia  selective androgen receptor modulators  sex hormones  testosterone
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号